Newamsterdam Pharma Company Nv Earnings

Newamsterdam Pharma Company Nv’s revenue fell -99.75% since last year same period to $0.03Mn in the Q4 2025. On a quarterly growth basis, Newamsterdam Pharma Company Nv has generated -90.8% fall in its revenue since last 3-months.

Newamsterdam Pharma Company Nv’s net profit jumped 18.72% since last year same period to $-74.92Mn in the Q4 2025. On a quarterly growth basis, Newamsterdam Pharma Company Nv has generated -4.05% fall in its net profits since last 3-months.

Newamsterdam Pharma Company Nv’s net profit margin fell -32341.54% since last year same period to -234134.38% in the Q4 2025. On a quarterly growth basis, Newamsterdam Pharma Company Nv has generated -1031.57% fall in its net profit margins since last 3-months.

Newamsterdam Pharma Company Nv’s earning per share (EPS) estimates for the current quarter stand at -0.47 - a -17.49% fall from last quarter’s estimates.

Newamsterdam Pharma Company Nv’s earning per share (EPS) estimates for the current year stand at -0.47.

Newamsterdam Pharma Company Nv’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q1 2026. This indicates that the Newamsterdam Pharma Company Nv has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.